Union Medical uses Photon Control’s optical sensors in medical device
Category: #health  By Mateen Dalal  Date: 2019-12-17
  • share
  • Twitter
  • Facebook
  • LinkedIn

Union Medical uses Photon Control’s optical sensors in medical device
  • The optical sensors are designed to integrate into Union Medical’s Neo Thermos
     
  • Neo Thermos is utilized to treat tumors without affecting the normal cells

Photon Control Inc., a developer and supplier of optical measurement technologies for semiconductor companies has recently announced that it will be expanding its addressable market with the launch of a new product by Union Medical Co. Ltd., a Korean-based manufacturer that produces electrosurgical, laser and various other aesthetic equipment.

The optical sensors and systems of Photon Control have been specially designed to be integrated into a medical device for high-frequency hyperthermia treatment of cancer, produced by Union Medical. The medical device is called Neo Thermos and is used to treat the tumors without having to affect the normal cells.

The temperature sensor systems made by Photon Control are generally used to monitor the temperature of the patients during their treatment. The fiber optic technology of the device is known to be immune to the radio frequency that is generated from the device.  

The Chief executive officer of Photon Control, Nigel Hunton stated that the company has taken the products to the medical industry as part of its growth strategy of willing to increase the addressable market. He further added that the expansion towards the medical sector will confirm Photon’s ability to influence their technology in several markets that share similar features with their core business.

The company has a strong market position within the semiconductor industry wherein it has been aiming to build on the existing technology as well as developing a know-how to be able to enter the near-adjacent markets.

Union Medical’s Chief Technology Officer, Bong Suek Kim commented that the firm is looking forward to working with Photon Control on Neo Thermos, an innovative device made to treat cancer without affecting the normal cells.

Kim added that Photon Control has had a proven solution within the semiconductor industry for years with a high level of reliability, repeatability, and accuracy of all their temperature systems and sensors.

 

Source Credit- https://www.photoncontrol.com/news-release/photon-control-expands-addressable-market-with-new-medical-application/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Microsoft to fix an active security flaw in Internet Explorer
Microsoft to fix an active security flaw in Internet Explorer
By Mateen Dalal

Microsoft, the renowned American tech giant, reportedly verified the presence of a security flaw that is affecting Internet Explorer (IE) and is being used by hackers. The company also said it is working to find a fix for this bug, which would be rel...

Dermtech signs a commercial & medicare advantage coverage agreement
Dermtech signs a commercial & medicare advantage coverage agreement
By Mateen Dalal

DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmented Lesion Assay) for prior detect...

CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
CoImmune Inc. inks all-stock merger deal with Formula Pharmaceutical
By Mateen Dalal

The merger will bring two therapeutic immune-oncology platforms together Focus shall be placed over Phase 1 and Phase 2 trials of CAR-CIK and CMN-001 respectively U.S.-based bioscience firm CoImmune, Inc., announces partnership with Formula Phar...